A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms

Eight hundred and eight patients with histologically proved malignant disease had carcinoembryonic antigen (CEA) estimations performed at the time of tissue diagnosis. An elevated level was found in 384 of 518 patients with gastrointestinal neoplasms (74 per cent) and in 162 of 290 patients with oth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery 1979-02, Vol.66 (2), p.120-123
Hauptverfasser: Cooper, M. J., Mackie, C. R., Skinner, D. B., Moossa, A. R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 2
container_start_page 120
container_title British journal of surgery
container_volume 66
creator Cooper, M. J.
Mackie, C. R.
Skinner, D. B.
Moossa, A. R.
description Eight hundred and eight patients with histologically proved malignant disease had carcinoembryonic antigen (CEA) estimations performed at the time of tissue diagnosis. An elevated level was found in 384 of 518 patients with gastrointestinal neoplasms (74 per cent) and in 162 of 290 patients with other neoplasms (56 per cent). No correlation was found between CEA elevations and tumour differentiation. There was a good correlation between tumour staging and CEA levels for patients with colorectal cancer; the more advanced the tumour, the higher the CEA. Several illustrative cases are presented and the role of CEA assay in the diagnosis and management of neoplasia is discussed. CEA assay is a poor screening test for neoplastic disease, but serial CEA monitoring is valuable in the detection of residual or recurrent cancer.
doi_str_mv 10.1002/bjs.1800660212
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11427820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74450112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3942-f867314c14f22de297cf0a65730b6061741b4f69469dc4ac008ac5b3a50a8d983</originalsourceid><addsrcrecordid>eNpVUUtv1DAQthCvpXDlxCEnbinjR2znhEoF26LykAqCmzXxOrtuEyfYScv-e7xstYXTzOh7jD0fIS8pHFMA9qa5SsdUA0gJjLIHZEG5rEpGpX5IFgCgSsoZf0qepXQFQDlU7Al5LBjUmi3I9UkRHY5jRJ-wK4a2mDauuMFudrvBYrQ-DK5v4nYI3hYYJr92ofDhL7HHgGvXuzDt2CNOPrepuPXTJptEP8ypCG4YO0x9ek4etdgl9-KuHpHvH95_Oz0rL74sz09PLkrLa8HKVkvFqbBUtIytHKuVbQFlpTg0EiRVgjailbWQ9coKtAAabdVwrAD1qtb8iLzd-45z07uVzU-K2Jkx-h7j1gzozf9I8BuzHm4MpYIpzSA7vL5ziMOv2aXJ9D5Z13WYPzMno4SogFKWia_-XXXYsT9vhus9fOs7tz2gFMwuOpOjM_fRmXcfL--nrC33Wp8m9_ugxXht8n1UZX58Xpqf6vIrVXppPvE_LbOeKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74450112</pqid></control><display><type>article</type><title>A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Cooper, M. J. ; Mackie, C. R. ; Skinner, D. B. ; Moossa, A. R.</creator><creatorcontrib>Cooper, M. J. ; Mackie, C. R. ; Skinner, D. B. ; Moossa, A. R.</creatorcontrib><description>Eight hundred and eight patients with histologically proved malignant disease had carcinoembryonic antigen (CEA) estimations performed at the time of tissue diagnosis. An elevated level was found in 384 of 518 patients with gastrointestinal neoplasms (74 per cent) and in 162 of 290 patients with other neoplasms (56 per cent). No correlation was found between CEA elevations and tumour differentiation. There was a good correlation between tumour staging and CEA levels for patients with colorectal cancer; the more advanced the tumour, the higher the CEA. Several illustrative cases are presented and the role of CEA assay in the diagnosis and management of neoplasia is discussed. CEA assay is a poor screening test for neoplastic disease, but serial CEA monitoring is valuable in the detection of residual or recurrent cancer.</description><identifier>ISSN: 0007-1323</identifier><identifier>EISSN: 1365-2168</identifier><identifier>DOI: 10.1002/bjs.1800660212</identifier><identifier>PMID: 420982</identifier><language>eng</language><publisher>Bristol: John Wiley &amp; Sons, Ltd</publisher><subject>Adult ; Aged ; Carcinoembryonic Antigen - analysis ; Colonic Neoplasms - immunology ; Colonic Neoplasms - pathology ; Female ; Gastrointestinal Neoplasms - immunology ; Humans ; Male ; Neoplasm Metastasis ; Neoplasm Staging ; Neoplasms - diagnosis ; Neoplasms - immunology ; Neoplasms - pathology ; Prognosis ; Rectal Neoplasms - immunology ; Rectal Neoplasms - pathology</subject><ispartof>British journal of surgery, 1979-02, Vol.66 (2), p.120-123</ispartof><rights>Copyright © 1979 British Journal of Surgery Society Ltd.</rights><rights>Copyright © 1979 British Journal of Surgery Society Ltd. 1979</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3942-f867314c14f22de297cf0a65730b6061741b4f69469dc4ac008ac5b3a50a8d983</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbjs.1800660212$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbjs.1800660212$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/420982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cooper, M. J.</creatorcontrib><creatorcontrib>Mackie, C. R.</creatorcontrib><creatorcontrib>Skinner, D. B.</creatorcontrib><creatorcontrib>Moossa, A. R.</creatorcontrib><title>A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms</title><title>British journal of surgery</title><addtitle>Br J Surg</addtitle><description>Eight hundred and eight patients with histologically proved malignant disease had carcinoembryonic antigen (CEA) estimations performed at the time of tissue diagnosis. An elevated level was found in 384 of 518 patients with gastrointestinal neoplasms (74 per cent) and in 162 of 290 patients with other neoplasms (56 per cent). No correlation was found between CEA elevations and tumour differentiation. There was a good correlation between tumour staging and CEA levels for patients with colorectal cancer; the more advanced the tumour, the higher the CEA. Several illustrative cases are presented and the role of CEA assay in the diagnosis and management of neoplasia is discussed. CEA assay is a poor screening test for neoplastic disease, but serial CEA monitoring is valuable in the detection of residual or recurrent cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Carcinoembryonic Antigen - analysis</subject><subject>Colonic Neoplasms - immunology</subject><subject>Colonic Neoplasms - pathology</subject><subject>Female</subject><subject>Gastrointestinal Neoplasms - immunology</subject><subject>Humans</subject><subject>Male</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Staging</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><subject>Prognosis</subject><subject>Rectal Neoplasms - immunology</subject><subject>Rectal Neoplasms - pathology</subject><issn>0007-1323</issn><issn>1365-2168</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUUtv1DAQthCvpXDlxCEnbinjR2znhEoF26LykAqCmzXxOrtuEyfYScv-e7xstYXTzOh7jD0fIS8pHFMA9qa5SsdUA0gJjLIHZEG5rEpGpX5IFgCgSsoZf0qepXQFQDlU7Al5LBjUmi3I9UkRHY5jRJ-wK4a2mDauuMFudrvBYrQ-DK5v4nYI3hYYJr92ofDhL7HHgGvXuzDt2CNOPrepuPXTJptEP8ypCG4YO0x9ek4etdgl9-KuHpHvH95_Oz0rL74sz09PLkrLa8HKVkvFqbBUtIytHKuVbQFlpTg0EiRVgjailbWQ9coKtAAabdVwrAD1qtb8iLzd-45z07uVzU-K2Jkx-h7j1gzozf9I8BuzHm4MpYIpzSA7vL5ziMOv2aXJ9D5Z13WYPzMno4SogFKWia_-XXXYsT9vhus9fOs7tz2gFMwuOpOjM_fRmXcfL--nrC33Wp8m9_ugxXht8n1UZX58Xpqf6vIrVXppPvE_LbOeKg</recordid><startdate>197902</startdate><enddate>197902</enddate><creator>Cooper, M. J.</creator><creator>Mackie, C. R.</creator><creator>Skinner, D. B.</creator><creator>Moossa, A. R.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>197902</creationdate><title>A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms</title><author>Cooper, M. J. ; Mackie, C. R. ; Skinner, D. B. ; Moossa, A. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3942-f867314c14f22de297cf0a65730b6061741b4f69469dc4ac008ac5b3a50a8d983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Carcinoembryonic Antigen - analysis</topic><topic>Colonic Neoplasms - immunology</topic><topic>Colonic Neoplasms - pathology</topic><topic>Female</topic><topic>Gastrointestinal Neoplasms - immunology</topic><topic>Humans</topic><topic>Male</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Staging</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><topic>Prognosis</topic><topic>Rectal Neoplasms - immunology</topic><topic>Rectal Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cooper, M. J.</creatorcontrib><creatorcontrib>Mackie, C. R.</creatorcontrib><creatorcontrib>Skinner, D. B.</creatorcontrib><creatorcontrib>Moossa, A. R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cooper, M. J.</au><au>Mackie, C. R.</au><au>Skinner, D. B.</au><au>Moossa, A. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms</atitle><jtitle>British journal of surgery</jtitle><addtitle>Br J Surg</addtitle><date>1979-02</date><risdate>1979</risdate><volume>66</volume><issue>2</issue><spage>120</spage><epage>123</epage><pages>120-123</pages><issn>0007-1323</issn><eissn>1365-2168</eissn><abstract>Eight hundred and eight patients with histologically proved malignant disease had carcinoembryonic antigen (CEA) estimations performed at the time of tissue diagnosis. An elevated level was found in 384 of 518 patients with gastrointestinal neoplasms (74 per cent) and in 162 of 290 patients with other neoplasms (56 per cent). No correlation was found between CEA elevations and tumour differentiation. There was a good correlation between tumour staging and CEA levels for patients with colorectal cancer; the more advanced the tumour, the higher the CEA. Several illustrative cases are presented and the role of CEA assay in the diagnosis and management of neoplasia is discussed. CEA assay is a poor screening test for neoplastic disease, but serial CEA monitoring is valuable in the detection of residual or recurrent cancer.</abstract><cop>Bristol</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>420982</pmid><doi>10.1002/bjs.1800660212</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1323
ispartof British journal of surgery, 1979-02, Vol.66 (2), p.120-123
issn 0007-1323
1365-2168
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11427820
source MEDLINE; Wiley Journals
subjects Adult
Aged
Carcinoembryonic Antigen - analysis
Colonic Neoplasms - immunology
Colonic Neoplasms - pathology
Female
Gastrointestinal Neoplasms - immunology
Humans
Male
Neoplasm Metastasis
Neoplasm Staging
Neoplasms - diagnosis
Neoplasms - immunology
Neoplasms - pathology
Prognosis
Rectal Neoplasms - immunology
Rectal Neoplasms - pathology
title A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A33%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20reappraisal%20of%20the%20value%20of%20carcinoembryonic%20antigen%20in%20the%20management%20of%20patients%20with%20various%20neoplasms&rft.jtitle=British%20journal%20of%20surgery&rft.au=Cooper,%20M.%20J.&rft.date=1979-02&rft.volume=66&rft.issue=2&rft.spage=120&rft.epage=123&rft.pages=120-123&rft.issn=0007-1323&rft.eissn=1365-2168&rft_id=info:doi/10.1002/bjs.1800660212&rft_dat=%3Cproquest_pubme%3E74450112%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74450112&rft_id=info:pmid/420982&rfr_iscdi=true